Recent AKLI News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:09:32 PM
- Akili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video Game • Business Wire • 06/18/2024 08:01:00 PM
- Form SC TO-T - Tender offer statement by Third Party • Edgar (US Regulatory) • 06/03/2024 09:21:27 PM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 05/29/2024 09:32:03 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 05/29/2024 08:05:28 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 05/29/2024 01:16:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:14:26 PM
- Virtual Therapeutics, Akili Interactive Enter Into Definitive Merger Agreement to Establish Leading Digital Health Company • Business Wire • 05/29/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:16:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:10:09 PM
- Akili Reports First Quarter 2024 Financial Results and Provides Business Update • Business Wire • 05/14/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 09:32:11 PM
- Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results • Business Wire • 04/30/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/06/2024 09:28:17 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/06/2024 09:11:56 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/06/2024 09:07:56 PM
- Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • Business Wire • 02/29/2024 09:01:00 PM
- PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan • Business Wire • 02/27/2024 07:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 02:04:31 PM
- Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan • Business Wire • 02/26/2024 01:47:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:43:26 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:28:43 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/23/2024 12:57:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:11:05 PM
- Akili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance Updates • Business Wire • 02/21/2024 09:05:00 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM